Strides Pharma completes acquisition of Neviton Softech
after close1 source ↓written by the desknot a recommendation
- in Neviton Softech
- 50% stake
- approximately
- €2 million
- approximately
- ₹21.77 cr
- effective
- 16 Feb 2026
Strides Pharma Science Limited confirmed the acquisition of the remaining 50% stake in Neviton Softech for €2 million (approximately ₹21.77 cr). This deal, effective from 16 Feb 2026, positions Neviton as a wholly owned subsidiary of Arco Lab, enhancing its capabilities in IT services and IoT devices. This strategic move supports Arco Lab’s digital transformation goals.
Not investment advice. For informational purposes only.